Iloprost - Wikipedia
网页Iloprost, sold under the brand name Ventavis among others, is a medication used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon, frostbite, and other conditions in which the blood vessels are constricted and …
全球首款治疗严重冻伤的药物伊洛前列素获FDA批准上市 - 知乎
网页2024年3月30日 · 全球首款治疗严重冻伤的药物伊洛前列素获FDA批准上市. 此前，美国FDA宣布批准由EicosSciences所开发的Aurlumyn（iloprost）注射液，用于治疗 成人严重冻伤（frostbite），以降低患者手指或脚趾截肢的风险。. 根据FDA新闻稿，Aurlumyn是用于治疗严重冻伤的首个获批药物 ...
Iloprost: Uses, Interactions, Mechanism of Action - DrugBank Online
网页Iloprost is a synthetic prostacyclin analog used to treat pulmonary arterial hypertension (PAH) and frostbites. Brand Names. Aurlumyn, Ventavis. Generic Name. Iloprost. DrugBank Accession Number. DB01088. Background. Iloprost is an analog of prostacyclin (PGI2; epoprostenol), an endogenous prostanoid mainly produced in the vascular endothelium.
Iloprost: MedlinePlus Drug Information
网页Iloprost is used to treat certain kinds of pulmonary arterial hypertension (PAH; high blood pressure in the vessels carrying blood to the lungs, causing shortness of breath, dizziness, and tiredness). Iloprost may improve the ability to exercise and slow the worsening of symptoms in patients with PAH. Iloprost is in a class of medications ...
Iloprost (Inhalation Route) Description and Brand Names - Mayo …
网页Iloprost inhalation is used to treat the symptoms of pulmonary arterial hypertension (PAH). This is high blood pressure that occurs in the main artery that carries blood from the right side of the heart (the ventricle) to the lungs.
Inhaled Iloprost for Severe Pulmonary Hypertension
网页2002年8月1日 · Inhaled iloprost is an effective therapy for patients with severe pulmonary hypertension. A continuous infusion of prostacyclin was the first therapy shown to reduce mortality in a controlled ...
Ventavis (iloprost) Uses, Dosage, Side Effects - Drugs.com
网页2024年5月3日 · Ventavis is an synthetic prostacyclin. It works by opening blood vessels in the lungs. Ventavis is a prescription medicine used to treat adults with certain kinds of severe pulmonary arterial hypertension (PAH). PAH is a condition in which blood pressure is too high in the blood vessels between the heart and the lungs.
Safety and tolerability of continuous inhaled iloprost in critically ...
网页2023年9月19日 · Inhaled iloprost (iILO) has shown efficacy in treating patients with hypoxic lung disease and pulmonary hypertension, inducing selective pulmonary vasodilation and improvement in oxygenation. However, its short elimination half‐life of 20–30 min necessitates frequent intermittent dosing (6–9 times per day).
Therapeutic iloprost for the treatment of acute respiratory distress ...
网页2020年3月4日 · The Therapeutic Iloprost during ARDS trial (ThIlo trial) is a multicenter, randomized, single blinded, clinical phase II trial assessing the efficacy of inhaled iloprost for the prevention of the development and progression of ARDS in critically ill patients.
Iloprost: Dosage, Mechanism/Onset of Action, Half-Life
网页2020年2月17日 · Mechanism of Action. Acutely, iloprost dilates systemic and pulmonary arterial vascular beds. With longer-term use, alters pulmonary vascular resistance and suppresses vascular smooth muscle proliferation. In addition, it is a mild endogenous inhibitor of platelet aggregation when aerosolized (Beghetti 2002).